Patient Out‐of‐Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims‐Based Study
Journal of Surgical Oncology · 2026
DOI: 10.1002/jso.70281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2026. Verfasst von Ellie M Proussaloglou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental, Mastectomy, Health Expenditures. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background and Objectives Out‐of‐pocket (OOP) costs and healthcare utilization remain unknown for women facing breast conservation and mastectomy.
Methods
Women aged 18–64 who underwent upfront breast cancer surgery were identified from the IBM MarketScan Commercial Claims Database (2014–2017). Surgical groups included lumpectomy+radiation; unilateral mastectomy + /‐reconstruction, and bilateral mastectomy + /‐reconstruction. Cumulative OOP payments were assessed at 12‐month intervals over 4 years postoperatively and adjusted to 2017 USD$. Multivariable regression identified factors associated with increased OOP costs.
Results
Overall, 23,159 underwent lumpectomy with radiation (60%), unilateral mastectomy with (15%) and without (6%) reconstruction, and bilateral mastectomy with (17%) and without (2.6%) reconstruction. Women undergoing bilateral mastectomy+reconstruction were younger than other surgical groups (median age 49 vs. 50–55). In the first year after diagnosis, 1.24 million outpatient visits occurred, 27% of enrollees had inpatient admissions, 23% visited an E.R., and median OOP costs were $5669 (range $0 to $132 125). Cumulative costs were significantly higher in women < 45 yo and for those with greater comorbidities. Median OOP costs declined over time (0–12 months: $3661 vs 48 months: $486). OOP costs were 12% higher (8.9%–15.1%) with mastectomy+reconstruction than lumpectomy+radiation ($6529 vs $5333).
Conclusions
Out‐of‐pocket costs and healthcare utilization differ between equally effective surgical treatment options; mastectomy + reconstruction is costlier for patients than breast conservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
- Smilow Cancer Center, Yale New Haven Health System, New Haven, Connecticut, USA.
- Artera Inc, Los Altos, California, USA.
- Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina, USA.
- Duke Cancer Institute, Durham, North Carolina, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Proussaloglou, E. M., Ren, Y., Fayanju, O. M., Blitzblau, R. C., Berger, E. R., Valero, M., Shelley Hwang, E., Wheeler, S. B., & Greenup, R. A. (2026). Patient Out‐of‐Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims‐Based Study. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70281
Vancouver
Proussaloglou EM, Ren Y, Fayanju OM, Blitzblau RC, Berger ER, Valero M, et al. Patient Out‐of‐Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims‐Based Study. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70281
BibTeX
@article{Proussaloglou2026,
author = {Proussaloglou, Ellie M and Ren, Yi and Fayanju, Oluwadamilola M and Blitzblau, Rachel C and Berger, Elizabeth R and Valero, Monica and Shelley Hwang, E and Wheeler, Stephanie B and Greenup, Rachel A},
title = {Patient Out‐of‐Pocket Costs and Healthcare Utilization Related to Mastectomy vs Breast Conservation: A Claims‐Based Study},
journal = {Journal of Surgical Oncology},
year = {2026},
doi = {10.1002/jso.70281}
}
EUVIMED